When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pheochromocytoma

Última revisão: 30 May 2025
Última atualização: 29 Apr 2025

Resumo

Definição

Анамнез и осмотр

Ключевые диагностические факторы

  • headache
  • palpitations
  • diaphoresis
  • hypertension
  • hypertensive retinopathy
  • pallor
  • impaired glucose tolerance/diabetes mellitus
  • family history of endocrine disorders
  • history of prior pheochromocytoma
  • tachyarrhythmias and myocardial infarction
  • panic attacks or a "sense of doom"
Полная информация

Другие диагностические факторы

  • orthostatic hypotension
  • hypercalcemia
  • Cushing syndrome
  • diarrhea
  • fever
  • papilledema
  • abdominal masses
  • tremors
Полная информация

Факторы риска

  • multiple endocrine neoplasia type 2 (MEN2)
  • Von Hippel-Lindau (VHL) disease
  • SDHB, SDHC, and SDHD gene mutations
  • neurofibromatosis type 1 (NF1)
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • plasma free metanephrines or 24-hour urine fractionated metanephrines and normetanephrines
  • genetic testing
Полная информация

Tests to avoid

  • plasma catecholamines
Полная информация

Исследования, проведение которых нужно рассмотреть

  • CBC
  • serum calcium
  • serum potassium
  • chromogranin A
  • clonidine suppression test
  • CT scan of the abdomen and pelvis
  • MRI of the abdomen and pelvis
  • 18F-fluorodeoxyglucose (18F-FDG) PET/CT or somatostatin receptor-targeted (SSTR) PET/CT with 68Ga-DOTATATE tracer
  • I-123 metaiodobenzylguanidine (MIBG) scintigraphy
Полная информация

Алгоритм лечения

Начальные

hypertensive crisis

Острый

without hypertensive crisis

Составители

Авторы

Bridget Sinnott, MD
Bridget Sinnott

Professor of Medicine

Medical College of Georgia

Augusta

GA

Раскрытие информации

BS declares that she has no competing interests.

Выражение благодарностей

Dr Bridget Sinnott would like to gratefully acknowledge Dr Sidhbh Gallagher, a previous contributor to this topic.

Раскрытие информации

SG declares that she has no competing interests.

Рецензенты

Betul A. Hatipoglu, MD

Clinical Endocrinologist and Research Scientist

Department of Endocrinology, Diabetes, and Metabolism

Cleveland Clinic

Cleveland

OH

Раскрытие информации

BAH declares that she has no competing interests.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019 Aug 8;381(6):552-65. Аннотация

Fishbein L, Del Rivero J, Else T, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma and paraganglioma. Pancreas. 2021 Apr 1;50(4):469-93.Полный текст  Аннотация

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroendocrine and adrenal tumors [internet publication].Полный текст

Kunz PL, Reidy-Lagunes D, Anthony LB, et al; North American Neuroendocrine Tumor Society. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013 May;42(4):557-77.Полный текст  Аннотация

Plouin PF, Amar L, Dekkers OM, et al; Guideline Working Group. European Society of Endocrinology clinical practice guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016 May;174(5):G1-10.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности